Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Ellen 't Hoen
51 POSTS
0 COMMENTS
http://medicineslawandpolicy.org
2018 Round-up of Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 26, 2018
New Database Documents the Power of TRIPS Flexibilities
Ellen 't Hoen
-
November 27, 2018
WIPO and pharma industry launch global medicines patent database
Ellen 't Hoen
-
September 27, 2018
Dutch health insurance company Menzis takes AstraZeneca to court over patent evergreening
Ellen 't Hoen
-
September 20, 2018
New Dutch Foundation to Address High Medicines Pricing Announces Plan to File Complaint with...
Ellen 't Hoen
-
August 25, 2018
Opmerkingen bij de notitie Dwanglicenties van B.J. Bruins, Minister voor Medische Zorg.
Ellen 't Hoen
-
July 10, 2018
European Pharmaceutical Legislation Needs Exceptions to Data and Market Exclusivity to Protect European Patients...
Ellen 't Hoen
-
May 21, 2018
Brazil’s Federal Court Reviews Medicines Mailbox Patents
Ellen 't Hoen
-
April 29, 2018
The Power of TRIPS Flexibilities in Medicines Procurement
Ellen 't Hoen
-
April 9, 2018
European Commission Publishes Expert Panel’s Recommendations on High Drug Prices
Ellen 't Hoen
-
February 20, 2018
1
...
3
4
5
6
Page 4 of 6
This work is licensed under Creative Commons.